Evidence map›Paper›PMID 36743904›Full record

ArticlePLOS global public health2022

Recruitment strategies and lessons learned from a large genetic study of African Americans.

Rebecca J Salowe, Roy Lee, Selam Zenebe-Gete, Marquis Vaughn, Harini V Gudiseva, Maxwell Pistilli, Ava Kikut, Emily Becker, David W Collins, Jie He and 14 more

Abstract read
In one paragraph

Article in PLOS global public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Rebecca J SaloweScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.
Roy LeeScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0001-7602-3979
Selam Zenebe-GeteScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.
Marquis VaughnScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.
Harini V GudisevaScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.
Maxwell PistilliScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0002-4266-4150
Ava KikutScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0002-1805-1020
Emily BeckerScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.
David W CollinsScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0002-0043-0129
Jie HeScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0001-8660-2501
Sayaka MerriamScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0003-3191-9979
Kristen MulvihillScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0002-1962-6842
Nora LabereeScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.
Sara Lomax-ReeseWURD Radio, Philadelphia, PA, United States of America.
Windell MurphyWindell Murphy, MD, Philadelphia, PA, United States of America.
Jeffrey HendererLewis Katz School of Medicine at Temple University, Philadelphia, PA, United States of America.ORCID 0000-0002-5446-3700
Venkata R M ChavaliScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0003-3439-3490
Qi N CuiScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0002-5338-0401
Ahmara G RossScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0002-7527-3121
Victoria AddisScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.
Prithvi S SankarScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0002-2978-3315
Eydie Miller-EllisScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0001-9710-9990
Maureen G MaguireScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0002-4249-2467
Joan M O'BrienScheie Eye Institute, University of Pennsylvania, Philadelphia, PA, United States of America.ORCID 0000-0003-4109-2928

Funding

Scientific TransparencyP30EY001583 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CLAIRE H MITCHELL · 1985 to 2026
$19.5M
Primary Open Angle African-American Glaucoma Genetics Study RenewalR01EY023557 · NEI · UNIVERSITY OF PENNSYLVANIA · PI O'BRIEN, JOAN M · 2014 to 2025
$18.1M
Mitochondrial Respiratory Chain Dysfunction in Primary Open Angle GlaucomaK08EY029765 · NEI · UNIVERSITY OF PENNSYLVANIA · PI CUI, QI N · 2019 to 2021
$731k
NEI NIH HHS K08 EY029765NEI NIH HHS L30 EY029353NEI NIH HHS P30 EY001583NEI NIH HHS R01 EY023557
6 · The paper itself

Abstract

Genetic studies must enroll large numbers of participants to obtain adequate statistical power. Data are needed on how researchers can best use limited financial and practical resources to achieve these targets, especially in under-represented populations. This paper provides a retrospective analysis of the recruitment strategies for a large glaucoma genetics study in African Americans. The Primary Open-Angle African American Glaucoma Genetics study enrolled 10,192 African American subjects from the Philadelphia region. Major recruitment approaches included clinic enrollment from University of Pennsylvania (UPenn) sites, clinic enrollment from external sites, sampling of Penn Medicine Biobank (PMBB), and community outreach. We calculated the enrollment yield, cost per subject, and seasonal trends of these approaches. The majority (65%) of subject were enrolled from UPenn sites with an average cost of $133/subject. Over time, monthly case enrollment declined as the pool of eligible subjects was depleted. Expanding to external sites boosted case numbers ($129/subject) and the biobank provided additional controls at low cost ($5/subject), in large part due to the generosity of PMBB providing samples free of cost. Community outreach was costly with low return on enrollment ($978/subject for 220 subjects). Summer months (Jun-Aug) produced the highest recruitment yields (p<0.001). Genetic studies will benefit from a multi-pronged and culturally sensitive recruitment approach. In our experience, the biobank was most cost-effective for control enrollment, while recruitment from clinics (including expansion to new sites) was necessary to recruit fully phenotyped cases.

Identifiers

PMID36743904
PMCPMC9897316

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.